AI
MRUS

Allostery Investments’s Merus MRUS Stock Holding History

Allostery Investments’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,000
Closed -$473K – 14
2025
Q2 		$473K Sell
9,000
-115,657
-93% -$5.44M 6.03% 7
2025
Q1 		$5.25M Buy
124,657
+102,922
+474% +$4.49M 7.57% 4
2024
Q4 		$914K Buy
+21,735
New +$1.04M 0.95% 20

Other funds holding MRUS

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Allostery Investments's MRUS Position: Q3 2025 in Review

Allostery Investments sold out of Merus (MRUS) in Q3 2025, closing a stake of 9,000 shares — an estimated $473K sold.

Allostery Investments first reported a position in MRUS in Q4 2024 and held it in 3 quarters. The position peaked at $5.25M in Q1 2025. 268 funds tracked by Wall St. Rank hold MRUS as of Q3 2025.

  • Allostery Investments reported no remaining Merus position as of Q3 2025 after selling out during the quarter.
  • Allostery Investments sold 9,000 Merus shares in Q3 2025, an estimated $473K.
  • Allostery Investments first reported a position in Merus in Q4 2024 and held it in 3 quarters.
  • Allostery Investments's Merus position peaked at $5.25M in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Merus as of Q3 2025.

Based on Allostery Investments's 13F filing for Q3 2025.